Effects of Black Soybean on Atherogenic Prevention in Hypercholesterolemic Rabbits and on Adhesion Molecular Expression in Cultured HAECs
Pi-Yu Chao1*, Yuh-Lien Chen2, Yi-Chu Lin3, Ju-Ing Hsu1,4, Kuan-Hung Lin5, Yi-Fa Lu4, Tien-Joung Yiu6, Meng-Yuan Huang7, Chi-Ming Yang7
1Department of Food, Health and Nutrition Science, Chinese Culture University, Taipei City.
2Department of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei City.
3Institute of Applied Life Science, Chinese Culture University, Taipei City.
4Department of Nutritional Science, Fu Jen Catholic University, Hsin-Chuang, Taipei City.
5Graduate Institute of Biotechnology, Chinese Culture University, Taipei City.
6Tainan District Agricultural Research and Extension Station-Potzu Branch Station, Council of Agriculture, Executive Yuan, Chiayi County.
7Research Center for Biodiversity, Academia Sinica, Taipei City.
DOI: 10.4236/fns.2013.48A002   PDF    HTML     4,157 Downloads   6,283 Views   Citations


The aim of the study was to investigate the effect of black soybean (BS) on the susceptibility of low-density lipoprotein (LDL) in hypercholesterolemic New Zealand white rabbits. Effects of the BS extract (BSE) and its components on monocyte adhesion of human aortic endothelial cells (HAECs), and adhesion molecule were investigated. Rabbits were divided into four groups, including control, 0.5% cholesterol with 20% casein (either with or without 0.5% vitamin E), and BS groups, all fed for 8 weeks. LDL was treated with 10 μM Cu2+ in vitro to determine the LDL lag time, and the vitamin E content of LDL was determined. The thickness of the tunica intima was measured on paraffin sections of thoracic aortas and aortic arches stained with Movat’s pentachrome. HAECs were pretreated with 100 μg/ml of BSE, and 10 μM of genistein, daidzein, cyanidin, and aspirin for 18 h, followed by tumor necrosis factor (TNF)-α (2 ng/ml) for 6 h, after which U937 cell adhesion was determined. Adhesion molecule expression was examined using ELISAs. The LDL lag time in the BS group was similar to that in the vitamin E group, while its lag time was significantly longer than those in the control and casein groups. The ratio of the intimal area/medial area of the aortic arch of the casein group was significantly higher than those in the control, BS, and vitamin E groups. The vitamin E group had the lowest value, and was closest to the control group. The BS group exhibited a significantly decreased atheroma region in the aortic arch compared to the casein group. Pre-incubation with BSE, genistein, daidzein, cyanidin, and aspirin significantly decreased adhesion by U937 monocytic cells to TNF-α stimulated HAECs. Genistein, daidzein, cyanidin, and aspirin significantly suppressed the expression of vascular cell adhesion molecule (VCAM)-1. Only genistein and aspirin significantly decreased intracellular adhesion molecule (ICAM)-1 expression compared to TNF-α treatment, while no treatments had any effect on E-selectin expression. BS significantly prolonged the LDL lag time and decreased the atheroma region of the aortic arch in hypercholesterolemic rabbits, thereby exerting an antiatherosclerotic effect. Presumably, the BSE downregulate intracellular redox-dependent signaling pathways in HAECs upon TNF-α stimulation through regulating NF-κB, thereby attenuating the inflammatory response in atherosclerosis. The antiatherogenic and anti-inflammatory effects of BS can be used as a nutraceutical for atherogenesis prevention.

Share and Cite:

P. Chao, Y. Chen, Y. Lin, J. Hsu, K. Lin, Y. Lu, T. Yiu, M. Huang and C. Yang, "Effects of Black Soybean on Atherogenic Prevention in Hypercholesterolemic Rabbits and on Adhesion Molecular Expression in Cultured HAECs," Food and Nutrition Sciences, Vol. 4 No. 8A, 2013, pp. 9-21. doi: 10.4236/fns.2013.48A002.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] D. Steinberg, “Lipoproteins and Atherogenesis,” Journal of the American Medical Association, Vol. 264, No. 23, 1990, pp. 3047-3052. doi:10.1001/jama.1990.03450230083034
[2] J. L. Witzum and D. Steinberg, “Role of Oxidized Low Density Lipoprotein in Atherogensis,” Journal of Clinical Investigation, Vol. 88, No. 6, 1991, pp. 1785-1792. doi:10.1172/JCI115499
[3] C. Suarna, R. T. Dean, J. May and R. Stocker, “Humann Atherosclerotic Plaque Contains Both Oxidized Lipid and Relatively Large Amounts of α-Tocopherpl and Ascorbate,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 15, No. 10, 1995, pp. 1616-1624. doi:10.1161/01.ATV.15.10.1616
[4] D. Steinberg, “Antioxidants and Atherosclerosis,” Circulation, Vol. 84, No. 3, 1991, pp. 1420-1425. doi:10.1161/01.CIR.84.3.1420
[5] I. Jialal and S. M. Grundy, “Effect of Combined Supplementation with α-Tocopherol, Ascorbate and β-Carotene on Low Density Lipoprotein Oxidation,” Circulation, Vol. 88, No. 6, 1993, pp. 2780-2786. doi:10.1161/01.CIR.88.6.2780
[6] N. G. Stephens, A. Parsons, P. M. Schofield, F. Kelly, K. Cheeseman, M. J. Mitchinson and M. J. Brown, “Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: Cambridge Heart Antioxidant Study (CHAOS),” Lancet, Vol. 347, No. 9004, 1996, pp. 781786. doi:10.1016/S0140-6736(96)90866-1
[7] E. B. Rimm, M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz and N. Willeet, “Vitamin E Consumption and the Risk of Coronary Heart Disease in Men,” New England Journal of Medicine, Vol. 328, No. 20, 1993, pp. 1450-1456. doi:10.1056/NEJM199305203282004
[8] M. J. Stampfer, C. H. Henneknes, J. E. Manson, G. A. Colditz, B. Rosner and W. C. Willett, “Vitamin E Consumption and the Risk of Coronary Disease in Women,” New England Journal of Medicine, Vol. 328, No. 20, 1993, pp. 1444-1449. doi:10.1056/NEJM199305203282003
[9] J. W. Anderson, B. M. Johnstone and M. E. Cook-Newell, “Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids,” New England Journal of Medicine, Vol. 333, 1995, pp. 276-282. doi:10.1056/NEJM199508033330502
[10] M. S. Anthony, T. B. Clarkson, B. C. Bullock and J. D. Wagner, “Soy Protein versus Soy Phytoestrogens in the Prevention of Diet-Induced Coronary Artery Atherosclerosis of Male Cynomolgus Monkeys,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, 1997, pp. 2524-2531. doi:10.1161/01.ATV.17.11.2524
[11] S. Kspiotis, M. Hermann, I. Held, C. Seelos, H. Ehringer and B. M. K. Gmeiner, “Genistein, the Dietary-Derived Angiogenesis Inhibitor, Prevents LDL Oxidation and Protects Endothelial Cells from Damage by Atherogenic LDL,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 11, 1997, pp. 2868-2874. doi:10.1161/01.ATV.17.11.2868
[12] R. Takahashi, R. Ohmori, C. Kiyose, Y. Momiyama, F. Ohsuzu and K. Kondo, “Antioxidant Activities of Black and Yellow Soybeans against Low Density Lipoprotein Oxidation,” Journal of Agricultural and Food Chemistry, Vol. 53, No. 11, 2005, pp. 4578-4582. doi:10.1021/jf048062m
[13] G. G. Kuiper, J. G. Lemmen, B. Carlsson, J. C. Corton, S. H. Safe, P. T. van der Saag, B. van der Burg and J. A. Gustafsson, “Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor Beta,” Endocrinology, Vol. 139, No. 10, 1998, pp. 4252-4263. doi:10.1210/en.139.10.4252
[14] R. C. Siow, F. Y. Li, D. J. Rowlands, P. de Winter and G. E. Mann, “Cardiovascular Targets for Estrogens and Phytoestrogens: Transcriptional Regulation of Nitric Oxide Synthase and Antioxidant Defense Genes,” Free Radical Biology and Medicine, Vol. 42, No. 7, 2007, pp. 909-925. doi:10.1016/j.freeradbiomed.2007.01.004
[15] J. Yamakoshi, M. K. Piskula, T. Izumi, K. Tobe, M. Saito, S. Kataoka, A. Obata and M. Kikuchi, “Isoflavone Aglycone-Rich Extract without Soy Protein Attenuates Atherosclerosis Development in Cholesterol-Fed Rabbits,” Journal of Nutrition, Vol. 130, No. 8, 2000, pp. 18871893.
[16] Q. H. Meng, P. Lewis, K. Wahala, H. Aadlercreutz and M. J. Tikkanen, “Incorporation of Esterified Soybean Isoflavones with Antioxidant Activity into Low Density Lipoprotein,” Biochimica et Biophysica Acta, Vol. 1438, No. 3, 1999, pp. 369-376. doi:10.1016/S1388-1981(99)00062-1
[17] H. Esterbauer, J. Gebicki, H. Puhl and G. Jurgens, “The Role of Lipid Peroxidation and Antioxidants in Oxidative Modification of LDL,” Free Radical Biology and Medicine, Vol. 13, No. 4, 1992, pp. 341-390. doi:10.1016/0891-5849(92)90181-F
[18] W. Palinski, “Conjunct Regulation of Aortic Antioxidant Enzymes during Atherogenesis,” Circulation Research, Vol. 93, No. 3, 2003, pp. 183-185. doi:10.1161/01.RES.0000087332.75244.42
[19] R. Ross, “The Pathogenesis of Atherosclerosis: A Perspective for the 1990s,” Nature, Vol. 362, No. 6423, 1993, pp. 801-809. doi:10.1038/362801a0
[20] P. Libby, “Molecular Basis of the Acute Coronary Syndromes,” Circulation, Vol. 91, 1995, pp. 2844-2850. doi:10.1161/01.CIR.91.11.2844
[21] Cybulsky M. I. and M. A. Gimbrone, “Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule during Atherogenesis,” Science, Vol. 251, No. 4995, 1991, pp. 788-791. doi:10.1126/science.1990440
[22] P. A. Baeuerle and D. Baltimore, “NF-kappa B: Ten Years after,” Cell, Vol. 87, No. 1, 1996, pp. 13-20. doi:10.1016/S0092-8674(00)81318-5
[23] J. A. DiDonato, M. Hayakawa, D. M. Rothwarf, E. Zandi and M. Karin, “A Cytokine-Responsive IkappaB Kinase that Activates the Transcription Factor NF-kappa B,” Nature, Vol. 388, 1997, pp. 548-554. doi:10.1038/41493
[24] J. M. Muller, R. A. Rupec and P. A. Baeuerle, “Study of Gene Regulation by NF-Kappa B and AP-1 in Response to Reactive Oxygen Intermediates,” Methods, Vol. 11, No. 3, 1997, pp. 301-312. doi:10.1006/meth.1996.0424
[25] S. B. Lotito and F. Balz, “Dietary Flavonoids Attenuate Tumor Necrosis Factor-α Induced Adhesion Molecule Expression in Human Aortic Endothelial Cells,” Journal of Biological Chemistry, Vol. 281, No. 48, 2006, pp. 3710237110. doi:10.1074/jbc.M606804200
[26] A. A. Ali, M. T. Velasquez, C. T. Hansen, A. I. Mohamed and S. J. Bhathena, “Effects of Soybean Isoflavones, Probiotics, and Their Interactions on Lipid Metabolism and Endocrine System in an Animal Model of Obesity and Diabetes,” Journal of Nutritional Biochemistry, Vol. 15, No. 10, 2004, pp. 583-590. doi:10.1016/j.jnutbio.2004.04.005
[27] B. L. McVeigh, B. L. Dillingham, J. W. Lampe and A. M. Duncan, “Effect of soy Protein Varying in Isoflavone Content on Serum Lipids in Healthy Young Men,” American Journal of Clinical Nutrition, Vol. 83, No. 2, 2006, pp. 244-251.
[28] G. Rimbach, C. Boesch-Saadatmandi, J. Frank, D. Fuchs, U. Wenzel, H. Daniel, W. L. Hall and P. D. Weinberg, “Dietary Isoflavones in the Prevention of Cardiovascular Disease A Molecular Perspective,” Food and Chemical Toxicology, Vol. 46, No. 4, 2008, pp. 1308-1319. doi:10.1016/j.fct.2007.06.029
[29] N. R. T. Damasceno, E. Apolinário, F. D. Flauzino, I. Fernandes and D. S. P. Abdalla, “Soy Isoflavones Reduce Electronegative Low-Density Lipoprotein (LDL-) and Anti-LDL-Autoantibodies in Experimental Atherosclerosis,” European Journal of Nutrition, Vol. 46, No. 3, 2007, pp. 125-132. doi:10.1007/s00394-006-0640-9
[30] S. Nagarajan, B. W. Stewart and T. M. Badger, “Soy Isoflavones Attenuate Human Monocyte Adhesion to Endothelial Cell-Specific CD54 by Inhibiting Monocyte CD11a,” Journal of Nutrition, Vol. 136, No. 9, 2006, pp. 2384-2390.
[31] T. Tsuda, K. Ohshima, S. Kawakishi and T. Osawa, “Antioxidative Pigments Isolated from the Seeds of Phaseolus vulgaris L,” Journal of Agricultural and Food Chemistry, Vol. 42, No. 2, 1994, pp. 248-251. doi:10.1021/jf00038a004
[32] B. J. Xu and S. K. C. Chang, “Antioxidant Capacity of Seed Coat, Dehulled Bean, and Whole Black Soybeans in Relation to Their Distributions of Total Phenolics, Phenolic Acids, Anthocyanins, and Isoflavones,” Journal of Agricultural and Food Chemistry, Vol. 56, No. 18, 2008, pp. 8365-8373. doi:10.1021/jf801196d
[33] R. F. Zhang, F. X. Zhang, M. W. Zhang, Z. C. Wei, C. Y. Yang, Y. Zhang, X. J. Tang, Y. Y. Deng and J. W. Chi, “Phenolic Composition and Antioxidant Activity in Seed Coats of 60 Chinese Black Soybean (Glycine max L. Merr.) Varieties,” Journal of Agricultural and Food Chemistry, Vol. 59, No. 11, 2011, pp. 5935-5944. doi:10.1021/jf201593n
[34] H. J. Kim, I. Tsoy, J. M. Park, J. I. Chung, S. C. Shin and K. C. Chang, “Anthocyanins from Soybean Seed Coat Inhibit the Expression of TNF-a-Induced Genes Associated with Ischemia/Reperfusion in Endothelial Cell by NF-κBDependent Pathway and Reduce Rat myocardial Damages Incurred by Ischemia and Reperfusion in Vivo,” FEBS Letters, Vol. 580, No. 5, 2006, pp. 1391-1397. doi:10.1016/j.febslet.2006.01.062
[35] B. J. Xu, S. H. Yuan and S. K. C. Chang, “Comparative Studies on the Antioxidant Activities of Nine Common Food Legumes against Copper-Induced Human Low-Density Lipoprotein Oxidation in Vitro,” Journal of Food Science, Vol. 72, No. 7, 2007, pp. S522-S527. doi:10.1111/j.1750-3841.2007.00464.x
[36] Y. F. Chen, S. L. Lee and C. C. Chou, “Fermentation with Aspergillus awamori Enhanced Contents of Amino Nitrogen and Total Phenolics as Well as the Low-Density Lipoprotein Oxidation Inhibitory Activity of Black Soybeans,” Journal of Agricultural and Food Chemistry, Vol. 59, No. 8, 2011, pp. 3974-3979. doi:10.1021/jf2001684
[37] H. J. Kim, L. Xu, K. C. Chang, S. C. Shin, J. I. Chung, D. Kang, S. H. Kim, J. A. Hur, T. H. Choi, S. Kim and J. Choi, “Anti-Inflammatory Effects of Anthocyanins from Black Soybean Seed Coat on the Keratinocytes and Ischemia-Reperfusion Injury in Rat Skin Flaps,” Microsurgery, Vol. 32, No. 7, 2012, pp. 1-8. doi:10.1002/micr.22019
[38] M. J. Tikkanen, K. Wahala, S. Ojala, V. Vihma and H. Adercreutz, “Effect of Soybean Phytoestrogen Intake on Low Density Lipoprotein Oxidation Resistance,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 6, 1998, pp. 31063110. doi:10.1073/pnas.95.6.3106
[39] C. C. Allain, L. S. Poon, C. S. G. Chan, W. Richmond and P. C. Fu, “Enzymatic Determination of Total Serum Cholesterol,” Clinical Chemistry, Vol. 20, No. 4, 1974, pp. 470-475.
[40] P. Fossati and L. Prencipe, “Serum Triglyceride Determined Colorimetrically with an Enzyme That Produces Hydrogen Peroxide,” Clinical Chemistry, Vol. 28, No. 10, 1982, pp. 2077-2080.
[41] A. L. Mancinelli, C. P. Huang Yang, P. Lindquist, O. R. Anderson and I. Rabino, “Photocontrol of Anthocyanin Synthesis III. The Action of Streptomycin on the Synthesis of Chlorophyll and Anthocyanin,” Plant Physiology, Vol. 55, No. 2, 1975, pp. 251-257.
[42] D. C. Sheehan and B. B. Hrapahak, “Theory and Practice of Histochnology,” 2nd Edition, Battelle Press, Columbus, 1987.
[43] V. N. Schumasker and D. L. Puppione, “Sequential Flotation Ultracentrifugation,” Methods in Enzymology, Vol. 128, 1986, pp. 155-170. doi:10.1016/0076-6879(86)28066-0
[44] H. A. Kleeinveld, H. L. M. Hak-Lemmers, A. F. H. Stalenhoef and P. N. M. Demacker, “Improved Measurement of Low Density Lipoprotein Susceptibility to CopperInduced Oxidation: Application of a Short Procedure for Isolating Low-Density Lipoprotein,” Clinical Chemistry, Vol. 38, No. 10, 1992, pp. 2066-2072.
[45] M. Podda, C. Weber, M. G. Traber and L. Packer, “Simultaneous Determination of Tissue Tocopherols, Tocotrienols, Ubiquinols, and Ubiquinones,” Lipid Research, Vol. 37, No. 4, 1996, pp. 893-901.
[46] T. H. Kao, Y. F. Lu and B. H. Chen, “Preparative Column Chromatography of Four Groups of Isoflavones from Soybean Cake,” European Food Research Technology, Vol. 221, No. 3-4, 2005, pp. 459-465. doi:10.1007/s00217-005-1206-4
[47] S. Vielma, G. Virella, A. J. Gorod and M. F. LopesVirella, “Chlamydophila Pneumonia Infection of Human Aortic Endothelial Cells Induces the Expression of FCγreceptor II (FcγRII),” Clinical Immunology, Vol. 104, No. 3, 2002, pp. 265-273. doi:10.1006/clim.2002.5237
[48] Y. H. Chen, S. J. Lin, J. W. Chen, H. H. Ku and Y. L. Chen, “Magnolol Attenuates VCAM-1 Expression in Vitro in TNF-α-Treated Human Aortic Endothelial Cells and in Vivo in the Aorta of Cholesterol-Fed Rabbits,” British Journal of Pharmacology, Vol. 135, No. 1, 2002, pp. 37-47. doi:10.1038/sj.bjp.0704458
[49] L. Wang, Y. C. Tu, T. W. Lian, J. T. Hung, J. H. Yen and M. J. Wu, “Distinctive Antioxidant and Antiinflammatory Effects of Flavonols,” Journal of Agricultural and Food Chemistry, Vol. 54, No. 26, 2006, pp. 9798-9804. doi:10.1021/jf0620719
[50] J. A. McCrohon, W. Jessup, D. J. Handelsman and D. S. Celermajer, “Androgen Exposure Increases Human Monocyte Adhesion to Vascular Endothelium and Endothelial Cell Expression of Vascular Cell Adhesion Molecule-1,” Circulation, Vol. 99, No. 17, 1999, pp. 2317-2322. doi:10.1161/01.CIR.99.17.2317
[51] J. Rutishauser, “The Role of Statins in Clinical MedicineLDL-Cholesterol Lowering and Beyond,” Swiss Medical Weekly, Vol. 136, No. 3-4, 2006, pp. 41-49.
[52] F. Balmir, R. Stacck, E. Jeffery, M. D. B. Jimenez, L. Wang and S. M. Potter, “An extract of Soy Flour Influences Serum Cholesterol and Thyroid Hormones in Rats and Hamsters.,” Journal of Nutrition, Vol. 126, No. 12, 1996, pp. 3046-3053.
[53] R. Faruqi, C. de la Motte and P. E. DiCorletto, “α-Tocopherol Inhibits Agonist-Induced Monocytic Cell Adhesion to Cultured Human Endothelial Cells,” Journal of Clinical Investigation, Vol. 94, No. 2, 1994, pp. 592-600. doi:10.1172/JCI117374
[54] R. A. Parker, T. Sabrah, M. Cap and B. T. Gill, “Relation of Vascular Oxidation Stress, α-Tocopherol and Hypercholesterolemia to Early Atherosclerosis in Hamsters,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 15, No. 3, 1995, pp. 349-358. doi:10.1161/01.ATV.15.3.349
[55] M. B. Ruiz-Larrea, A. Mohan, N. J. Miller, G. P. Bolwell and C. A. Rice-Evans, “Antioxidant Activity of Phytoestrogenic Isoflavones,” Free Radical Research, Vol. 26, No. 1, 1997, pp. 63-70. doi:10.3109/10715769709097785
[56] J. Y. A. Lehtonen, H. Adercreutz and P. K. J. Kinnunen, “Binding of Daidzein to Liposomes,” Biochimica et Biophysica Acta, Vol. 1285, No. 1, 1996, pp. 91-100. doi:10.1016/S0005-2736(96)00154-X
[57] M. J. Tikkanen and H. Adlercreutz, “Dietary Soy-Derived Isoflavone Phytoestrogens. Could They Have a Role in Coronary Disease Prevention?” Biochemical Pharmacology, Vol. 60, No. 1, 2000, pp. 1-5. doi:10.1016/S0006-2952(99)00409-8
[58] H. Esterbauer, G. Striegl, H. Puhl, S. Oberreither, M. Rotheneder, M. El-Saadani and G. Jurgens, “The Role of Vitamin E Consumption and the Caroteniods in Preventing Oxidation of Low Density Lipoprotein,” Annals of the New York Academy of Sciences, Vol. 570, No. 1, 1989, pp. 254-267. doi:10.1111/j.1749-6632.1989.tb14925.x
[59] A. V. Rao and S. Agarwal, “Bioavailability and in Vivo Antioxidant Properties of Lycopene from Tomato Products and Their Possible Role in the Prevention of Cancer,” Nutrition and Cancer, Vol. 31, No. 3, 1998, pp. 199-203. doi:10.1080/01635589809514703
[60] L. B. Tijburg, S. A. Wiseman, G. W. Meijer and J. A. Weststrate, “Effects of Green Tea, Black Tea and Dietary Lipophilic Antioxidants on LDL Oxidizability and Atherosclerosis in Hypercholesterolaemic Rabbits,” Atherosclerosis, Vol. 135, No. 1, 1997, pp. 37-47. doi:10.1016/S0021-9150(97)00139-1
[61] T. L. Yang, F. Y. Lin, Y. H. Chen, J. J. Chiu, M. S. Shiao, C. S. Tsai, S. J. Ling and Y. L. Chen, “Salvianolic Acid B Inhibits Low-Density Lipoprotein Oxidation and Neointimal Hyperplasia in Endothelium-Denuded Hypercholesterolaemic Rabbits,” Journal of Agricultural and Food Chemistry, Vol. 91, No. 1, 2011, pp. 134-141. doi:10.1002/jsfa.4163
[62] K. Yoshikura and Y. Hamaguchi, “Anthocyanins of the Black Soybean,” Eiiyo to Shohuryo, Vol. 22, No. 6, 1969, pp. 367-371. doi:10.4327/jsnfs1949.22.367
[63] A. J. Lusis, “Atherosclerosis,” Nature, Vol. 407, No. 6801, 2000, pp. 233-241. doi:10.1038/35025203
[64] C. Gerard and B. J. Rollins, “Chemokines and Disease,” Nature Immunology, Vol. 2, No. 2, 2001, pp. 108-115. doi:10.1038/84209
[65] T. Koga and M. Meydani, “Effect of Plasma Metabolites of (+)-Catechin and Quercetin on Monocyte Adhesion to Human Aortic Endothelial cells,” American Journal of Clinical Nutrition, Vol. 73, No. 5, 2001, pp. 941-948.
[66] C. Meng, P. Somers, L. Hoong, X. Zheng, Z. Ye, K. Worsencroft, J. Simpson, M. Hotema, M. Weingarten, M. MacDonald, R. Hill, E. Marino, K. Suen, J. Luchoomun, C. Kunsch, L. Landers, D. Stefanopoulos, R. Howard, C. Sundell, U. Saxena, M. Wasserman and L. Sikorski, “Discovery of Novel Phenolic Antioxidants as Inhibitors of Vascular Cell Adhesion Molecule-1 Expression for Use in Chronic Inflammatory Diseases,” Journal of Medicinal Chemistry, Vol. 47, No. 25, 2004, pp. 6420-6432. doi:10.1021/jm049685u
[67] P. E. McGregor, D. K. Agrawal and J. D. Edwards, “Attenuation of Human Leukocyte Adherence to Endothelial Cell Monolayers by Tyrosine Kinase Inhibitors,” Biochemical and Biophysical Research Communications, Vol. 198, No. 1, 1994, pp. 359-365. doi:10.1006/bbrc.1994.1050
[68] C. Weber, E. Negrescu, W. Erl, A. Pietsch, M. Frankenberger, H. W. Ziegler-Heitbrock, W. Siess and P. C. Weber, “Inhibitors of Protein Tyrosine Kinase Suppress TNF-Stimulated Induction of Endothelial Cell Adhesion Molecules,” Journal of Immunology, Vol. 155, No. 1, 1995, pp. 445-451.
[69] M. J. May, C. P. Wheeler-Jones and J. D. Pearson, “Effects of Protein Tyrosine Kinase Inhibitors on CytokineInduced Adhesion Molecule Expression by Human Umbilical Vein Endothelial Cells,” British Journal of Pharmacology, Vol. 118, No. 7, 1996, pp. 1761-1771. doi:10.1111/j.1476-5381.1996.tb15602.x
[70] E. Majewska, E. Paleolog, Z. Baj, U. Kralisz, M. Feldmann and H. Tchorzewski, “Role of Tyrosine Kinase Enzymes in TNF-alpha and IL-1 Induced Expression of ICAM-1 and VCAM-1 on Human Umbilical Vein Endothelial Cells,” Scandinavian Journal of Immunology, Vol. 45, No. 4, 1997, pp. 385-392. doi:10.1046/j.1365-3083.1997.d01-412.x
[71] C. Weber, “Involvement of Tyrosine Phosphorylation in Endothelial Adhesion Molecule Induction,” Immunology Research, Vol. 15, No. 1, 1996, pp. 30-37. doi:10.1007/BF02918282
[72] S. J. Chinta, A. Ganesan, P. Reis-Rodrigues, G. J. Lithgow and J. K. Andersen, “Anti-Inflammatory Role of the Isoflavone Diadzein in Lipopolysaccharide-Stimulated Microglia: Implications for Parkinson’s Disease,” Neurotoxicity Research, Vol. 23, No. 2, 2013, pp. 145-53. doi:10.1007/s12640-012-9328-5
[73] B. K. Chacko, R. T. Chandler, A. Mundhekar, N. Khoo, H. M. Pruitt, D. F. Kucik, D. A. Parks, C. G. Kevil, S. Barnes and R. P. Patel, “Revealing Anti-Inflammatory Mechanisms of Soy Isoflavones by Flow: Modulation of Leukocyte Endothelial Cell Interactions,” American Journal of Physiology-Heart and Circulatory Physiology, Vol. 289, No. 2, 2005, pp. H908-H915. doi:10.1152/ajpheart.00781.2004
[74] B. Madan, S. B. Batra and B. Ghosh, “2’-Hydroxychalcone Inhibits Nuclear Factor-Kappa B and Blocks Tumor Necrosis Factor-Alphaand Lipopllysaccharde-Induced Adhesion of Neutropophils to Human Umbilical Vein Endothelial Cells,” Molecular Pharmacology, Vol. 58, No. 3, 2000, pp. 526-534.
[75] B. Madan, W. N. Gade and B. Ghosh, “Curcuma Longa Acticates NF-KappaB and Promotes Adhesion of Neutrophils to Human Umbilical Vein Endothelial Cells,” Journal of Ethnopharmacology, Vol. 75, No. 1, 2001, pp. 2532. doi:10.1016/S0378-8741(00)00386-X
[76] T. J. Kalogeris, C. G. Kevil, F. S. Laroux, L. L. Coe, T. J. Phifer and J. S. Alexander, “Differential Monocyte Adhesion and Adhesion Molecule Expression in Venous and Arterial Endothelial Cells,” American Journal of Physiology, Vol. 276, No. 1, 1999, pp. L9-L19.
[77] A. C. van der Wal and A.E. Becker, “Atherosclerotic Plaque Rupture-Pathologic Basis of Plaque Stability and Instability,” Cardiovascular Research, Vol. 41, No. 2, 1999, pp. 334-344. doi:10.1016/S0008-6363(98)00276-4
[78] A. B. Lentsch and P. A. Ward, “Regulation of Inflammatory Vascular Damage,” Journal of Pathology, Vol. 190, No. 3, 2000, pp. 343-348. doi:10.1002/(SICI)1096-9896(200002)190:3<343::AID-PATH522>3.0.CO;2-M
[79] V. Garcia-Mediavilla, I. Crespo, P. S. Collado, A. Esteller, S. Sánchez-Campos, M. J. Tonon and J. González-Gallego, “The Anti-Inflammatory Flavones Quercetin and Kaempferol Cause Inhibition of Inducible Nitric Oxide Synthase, Cyclooxygenase-2 and Reactive C-Protein, and DownRegulation of the Nuclear Factor KappaB Pathway in Chang Liver Cells,” European Journal of Pharmacology, Vol. 557, No. 2-3, 2007, pp. 221-229. doi:10.1016/j.ejphar.2006.11.014
[80] S. W. Min, S. N. Ryu and D. H. Kim, “Anti-Inflammatory Effects of Black Rice, Cyaniding-3-O-β-D-Glycoside, and Its Metabolites, Cyanidin and Protocatechuic Acid,” International Immunopharmacology, Vol. 10, No. 8, 2010, pp. 959-966. doi:10.1016/j.intimp.2010.05.009

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.